2011
DOI: 10.3233/jad-2011-101608
|View full text |Cite
|
Sign up to set email alerts
|

Disturbed Choline Plasmalogen and Phospholipid Fatty Acid Concentrations in Alzheimer's Disease Prefrontal Cortex

Abstract: Alzheimer disease (AD) is a progressive neurodegenerative disorder characterized by brain deposition of senile (neuritic) plaques containing β-amyloid, neurofibrillary tangles, synaptic loss, neuroinflammation, and overexpression of arachidonic acid (AA, 20:4n-6) metabolizing enzymes. Lipid concentration changes have been reported in different brain regions, but often partially and/or as a percent of the total concentration. In this study, we measured absolute concentrations (per gram wet weight) of a wide ran… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

11
109
1
1

Year Published

2014
2014
2023
2023

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 166 publications
(122 citation statements)
references
References 82 publications
11
109
1
1
Order By: Relevance
“…Previously, low levels of ethanolamine plasmalogens have been reported in brain and serum from Alzheimer's disease patients [52,53], as well as decreased choline plasmalogens in brain [54]. Similarly, a decrease in plasmalogens is observed in our results, both in ethanolamine and choline plasmalogens ( Table 1).…”
Section: Membrane Destabilizationsupporting
confidence: 85%
“…Previously, low levels of ethanolamine plasmalogens have been reported in brain and serum from Alzheimer's disease patients [52,53], as well as decreased choline plasmalogens in brain [54]. Similarly, a decrease in plasmalogens is observed in our results, both in ethanolamine and choline plasmalogens ( Table 1).…”
Section: Membrane Destabilizationsupporting
confidence: 85%
“…DHA has a number of pro-cell survival roles within cell membranes, including the production of anti-inflammatory D-series resolvins and neuroprotectins (Weylandt et al 2012). DHA is known to be severely reduced in many regions of the brain affected by AD pathology (Söderberg et al 1991;Martín et al 2010;Igarashi et al 2011;Cunnane et al 2012;Fabelo et al 2014); however, there are very few studies of this type looking specifically at the changes to the EC. Only a single study has examined the EC for changes in its phospholipids in AD, finding no changes in either total PC, PE or PS (Chan et al 2012).…”
Section: Discussionmentioning
confidence: 99%
“…• Proteins should be extracted from fresh or snap frozen material at -70°C or below 184,210,234 • Lipids should be extracted from fresh or snap frozen material at -20°C 108 or -80°C 223,287 Time to freeze • Freeze immediately after isolation. Samples derived postmortem should be frozen (at -80°C) short after death (maximum 2 h) for optimal results in protein studies and to avoid protein degradation 210,234 • Freeze immediately after isolation.…”
Section: Parametermentioning
confidence: 99%
“…287 Different lipid subtypes can be successfully quantified by using mass spectrometric detection coupled with either gas, liquid, or thinlayer chromatography. 108,222,223,295 Tandem mass spectrometry with a lipid database 296 can be used to discriminate among chemical lipid variants with identical masses due to the identical number of acylic carbons and double bonds. 287 Matrix-assisted laser desorption/ ionization mass spectrometry permits the direct scanning of tissue slides, and it thus identifies the precise localization of different lipids in the tissue.…”
Section: Lipid Isolationmentioning
confidence: 99%